Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes. [electronic resource]
- Journal of autoimmunity Nov 2017
- 65-74 p. digital
Publication Type: Journal Article
1095-9157
10.1016/j.jaut.2017.07.006 doi
Animals Antibodies, Monoclonal--therapeutic use Diabetes Mellitus, Type 1--immunology Disease Models, Animal Drug Therapy, Combination Female Humans Hyperglycemia--immunology Immunotherapy--methods Insulin--genetics Insulin-Secreting Cells--immunology Interleukins--immunology Liraglutide--therapeutic use Mice Mice, Inbred NOD Mice, Transgenic Interleukin-21